MAP Podcast #001: Dr. Matthias Flume – AMNOG will change in 2022, but how?

In this Podcast episode, Dr. Stefan Walzer is talking with Dr. Mathias Flume about the AMNOG process as well as interesting details about the market access process in Germany.

Mathias is a core stakeholder within the regional payer system in Germany at one of the most innovative Statutory Health Insurance Physician Associations (KV Westphalia-Lippe). Mathias brings the payer view into the discussion of 10 years AMNOG. Success or failure?

 

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

There is more than Mozart, Sissi and Sacher cake! The pragmatic reimbursement pathways in Austria?!

Austria is in the center of Europe and has a high quality health care system. Recently there have been major changes within the insurance system which might also have longer term impact on reimbursement. Currently reimbursement pathways are seen as more pragmatic in comparison to other countries – not only in the inpatient setting. Listen and learn from the Austrian experts Dr. Stefan Walzer and Dr. Thorsten Peske.

Register now!

Price negotiations in Germany – live and let die or die hard?!

Price negotiations for drugs follow clear and strict frames and rules in Germany. Anyhow, there is flexibility in terms of negotiations and price anchors including the tactical move into an arbitration board decision. Even more important is the related contract between the head association of statutory health insurance fund and the respective pharma company. The experienced negotiator Dr. Stefan Walzer and Bibiane Schulte-Bosse will discuss whether the process is a „live and let die“ or „die hard“ – from the different perspectives.

Register now!